We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+2.16%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$34.7B
AUM Growth
+$242M
(+0.7%)
Cap. Flow
-$120M
Cap. Flow
% of AUM
-0.35%
Top 10 Holdings %
Top 10 Hldgs %
14.95%
Holding
3,089
New
65
Increased
2,336
Reduced
597
Closed
54
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$47.6M |
| 2 |
Medtronic
MDT
|
+$41.4M |
| 3 |
SLB Ltd
SLB
|
+$25M |
| 4 |
American Airlines Group
AAL
|
+$19.2M |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$18.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$107M |
| 2 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$68.5M |
| 3 |
Apple
AAPL
|
+$22.9M |
| 4 |
CFN
CAREFUSION CORPORATION
CFN
|
+$16.9M |
| 5 |
PETM
PETSMART INC
PETM
|
+$14M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.74% |
| 2 | Financials | 14.67% |
| 3 | Healthcare | 14.62% |
| 4 | Industrials | 10.93% |
| 5 | Consumer Discretionary | 9.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
951
SS&C Technologies
SSNC
$19B
| $4.04M | 0.01% |
129,832
+19,750
| +18% | +$587K |
|
|
SFG
952
DELISTED
STANCORP FINL GRP
SFG
| $4.03M | 0.01% |
58,773
-3,330
| -5% | -$222K |
|
|
DCT
953
DELISTED
DCT Industrial Trust Inc.
DCT
| $4.02M | 0.01% |
115,945
-3,840
| -3% | -$139K |
|
|
HSNI
954
DELISTED
HSN, Inc.
HSNI
| $4.02M | 0.01% |
58,884
+6,175
| +12% | +$435K |
|
955
Manitowoc
MTW
$519M
| $4.02M | 0.01% |
205,688
+48,906
| +31% | +$917K |
|
|
DNKN
956
DELISTED
Dunkin' Brands Group, Inc.
DNKN
| $4.01M | 0.01% |
84,348
+660
| +0.8% | +$30.6K |
|
957
Pool Corp
POOL
$7.39B
| $4M | 0.01% |
57,336
+5,285
| +10% | +$353K |
|
|
HRC
958
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
| $3.99M | 0.01% |
81,493
+4,399
| +6% | +$209K |
|
959
iShares Russell 1000 Growth ETF
IWF
$127B
| $3.99M | 0.01% |
161,340
+127,400
| +375% | +$3.11M |
|
|
CHS
960
DELISTED
Chicos FAS, Inc.
CHS
| $3.99M | 0.01% |
225,509
+18,953
| +9% | +$329K |
|
961
Toro Company
TTC
$9.44B
| $3.98M | 0.01% |
113,602
+3,100
| +3% | +$103K |
|
|
AVNS
962
DELISTED
Avanos Medical
AVNS
| $3.97M | 0.01% |
80,726
+3,164
| +4% | +$147K |
|
963
SITE Centers
SITC
$166M
| $3.97M | 0.01% |
165,463
+1,816
| +1% | +$44.8K |
|
|
CTB
964
DELISTED
Cooper Tire & Rubber Co.
CTB
| $3.97M | 0.01% |
92,590
+65
| +0.1% | +$2.4K |
|
|
ADVS
965
DELISTED
Advent Software Inc
ADVS
| $3.94M | 0.01% |
89,443
+12,148
| +16% | +$500K |
|
|
CAVM
966
DELISTED
Cavium, Inc.
CAVM
| $3.94M | 0.01% |
55,673
+8,450
| +18% | +$549K |
|
|
ABMD
967
DELISTED
Abiomed Inc
ABMD
| $3.94M | 0.01% |
55,073
+5,930
| +12% | +$322K |
|
968
Voya Financial
VOYA
$9.13B
| $3.93M | 0.01% |
91,122
+3,575
| +4% | +$151K |
|
|
RYL
969
DELISTED
RYLAND GROUP INC
RYL
| $3.92M | 0.01% |
80,403
+2,020
| +3% | +$86.4K |
|
970
Synaptics
SYNA
$4.16B
| $3.92M | 0.01% |
48,195
+5,860
| +14% | +$442K |
|
971
Silgan Holdings
SLGN
$4.47B
| $3.92M | 0.01% |
134,688
+7,836
| +6% | +$218K |
|
972
New York Times
NYT
$12.2B
| $3.91M | 0.01% |
284,096
+13,820
| +5% | +$185K |
|
|
PVTB
973
DELISTED
PrivateBancorp Inc
PVTB
| $3.91M | 0.01% |
111,088
+1,155
| +1% | +$39K |
|
|
QGENF
974
DELISTED
QIAGEN NV
QGENF
| $3.9M | 0.01% |
154,917
+1,271
| +0.8% | +$32K |
|
975
Commercial Metals
CMC
$8.03B
| $3.9M | 0.01% |
241,033
+10,678
| +5% | +$156K |
|
Similar funds
VAM
RhumbLine Advisers's Q1 2015 Portfolio in Review
As of Q1 2015, RhumbLine Advisers held 3,089 positions worth $34.7B, up 0.7% from $34.4B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Trading was light in Q1 2015: portfolio turnover was 3.9%. RhumbLine Advisers opened 65 new positions and exited 54, leaving the 3,089-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 15% a quarter earlier, followed by Financials and Healthcare.
- RhumbLine Advisers's largest Q1 2015 buy was Qorvo: 254,331 shares worth $20.3M.
- RhumbLine Advisers added most to Allergan plc in Q1 2015, an estimated $47.6M increase.
- RhumbLine Advisers's biggest Q1 2015 reduction was Apple, cutting an estimated $22.9M.
- RhumbLine Advisers fully exited Allergan Inc in Q1 2015, selling an estimated $107M.
- RhumbLine Advisers's ten largest holdings make up 15% of its $34.7B portfolio in Q1 2015.
- RhumbLine Advisers opened 65 new positions and closed 54 in Q1 2015.
- RhumbLine Advisers's portfolio value rose 0.7% quarter-over-quarter to $34.7B.
Based on RhumbLine Advisers's 13F filing for Q1 2015, filed 12 May 2015.